Spanish Red Biotech Pipeline

Merck KGaA

Xevinapant IAP inhibitor

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: Locally advanced squamous cell carcinoma of the head and neck
Phase: 3Phase III in Spain, 2Phase II, 1Phase I